Matthew Plavan
2011 - Cesca Therapeutics
In 2011, Matthew Plavan earned a total compensation of $550K as Chief Executive Officer at Cesca Therapeutics, a 35% increase compared to previous year.
Compensation breakdown
| Bonus | $89,000 |
|---|---|
| Option Awards | $92,000 |
| Salary | $301,000 |
| Stock Awards | $68,000 |
| Total | $550,000 |
Plavan received $301K in salary, accounting for 55% of the total pay in 2011.
Plavan also received $89K in bonus, $92K in option awards and $68K in stock awards.
Rankings
In 2011, Matthew Plavan's compensation ranked 7,735th out of 10,747 executives tracked by ExecPay. In other words, Plavan earned more than 28.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,735 out of 10,747 | 28th |
Division Manufacturing | 2,836 out of 3,960 | 28th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 423 out of 647 | 35th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 155 out of 230 | 33rd |
Industry Laboratory Apparatus and Furniture | 2 out of 12 | 83rd |
Source: SEC filing on April 4, 2014.
Plavan's colleagues
We found five more compensation records of executives who worked with Matthew Plavan at Cesca Therapeutics in 2011.
2011
J Engle
Cesca Therapeutics
Chief Executive Officer
2011
Hal Baker
Cesca Therapeutics
V.P., Commercial Operations & Marketing
2011
Jorge Artiles
Cesca Therapeutics
V.P., regulatory & Scientific Affairs, Chief Quality Officer
2011
Moni Shavit
Cesca Therapeutics
Former V.P., Engineering
2011
Ken Pappa
Cesca Therapeutics
V.P., Engineering & Manufacturing
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019